Stem Cells Clinical Trials This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaInterventions: Drug: carfilzomib; Drug: melphalan; Procedure: autologous bone marrow transplantation; Procedure: autologous hematopoietic stem cell transplantation; Other: laboratory biomarker analysisSponsors: Mayo Clinic; Mayo ClinicNot yet recruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2013 Category: Research Source Type: clinical trials

A Single Arm, Open-label Study to Evaluate the Safety and Tolerability of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies
Condition: Hematological MalignanciesIntervention: Drug: KRP203Sponsors: Novartis; Novartis PharmaceuticalsNot yet recruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2013 Category: Research Source Type: clinical trials

A Phase III Multicenter, Randomized Study Comparing Consolidation With 90yttrium-Labeled Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy Versus Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed Follicular Lymphoma (FL)
Condition: Relapsed Follicular LymphomaInterventions: Other: ZEVALIN; Drug: BEAMSponsors: Fondazione Italiana Linfomi ONLUS; Fondazione Italiana Linfomi ONLUSRecruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2013 Category: Research Source Type: clinical trials

Ipilimumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplantation
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Chronic Myelomonocytic Leukemia;...
Source: ClinicalTrials.gov - April 1, 2013 Category: Research Source Type: clinical trials

Data Demonstrating the Safety and Efficacy of Chimerix's Antiviral CMX001 Presented at BMT Tandem Meetings
- No evidence of CMX001-associated kidney toxicity was seen in stem cell transplant recipients who were enrolled in a 230-patient Phase 2 study to evaluate CMX001 for prevention of cytomegalovirus (CMV) infection. Subjects on CMX001 had stable to... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

Verastem to Present at Keystone Symposia on PI3 Kinase
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 20, 2013 - Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 20, 2013 Category: Pharmaceuticals Source Type: clinical trials

Stem Cell Transplantation Safe For Elderly Patients
ARLINGTON HEIGHTS, Ill., Feb. 19, 2013 /PRNewswire-USNewswire/ -- Researchers have shown that stem cell transplantation for elderly patients with blood cancers, such as leukemia, lymphoma or myelodysplastic syndrome (MDS), is safe and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 19, 2013 Category: Pharmaceuticals Source Type: clinical trials

Positive Data From Celldex's Phase 1 Study of CDX-301 Support Initiation of Pilot Study in Hematopoietic Stem Cell Transplantation
Final Study Results Presented in an Oral Session at the 2013 BMT Tandem Meetings NEEDHAM, Mass., Feb. 14, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) presented final results yesterday from a Phase 1 study of CDX-301... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 15, 2013 Category: Pharmaceuticals Source Type: clinical trials

Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation
Condition: Hematologic MalignanciesIntervention: Drug: ramosetronSponsors: The Catholic University of Korea; The Catholic University of KoreaNot yet recruiting - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2013 Category: Research Source Type: clinical trials

Scientific Data on PI3K/mTOR Inhibitor VS-5584 Published in Molecular Cancer Therapeutics
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 6, 2013 - Verastem, Inc., (NASDAQ: VSTM), a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 6, 2013 Category: Pharmaceuticals Source Type: clinical trials

Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes MellitusIntervention: Biological: Autologous stem cells and hyperbaric oxygen therapySponsors: University of Miami; Rodolfo Alejandro; University of MiamiActive, not recruiting - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2013 Category: Research Source Type: clinical trials